Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Surgery ; 114(2): 218-25; discussion 226, 1993 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8393595

RESUMO

BACKGROUND: Immunocompromised organ transplant recipients have a high incidence of B cell lymphomas (BCL). Severe combined immunodeficient (SCID) mice develop human BCL when engrafted with Epstein-Barr virus (EBV) transformed and immortalized B lymphoblastoid cell lines (BLCL). Because a lack of effective EBV-specific cytotoxic T lymphocytes (EBV-CTL) is thought to lead to lymphoma development, the SCID mouse model was used to determine the relationship between EBV-infected B cells and EBV-specific CTL in BCL development in vivo. METHODS: EBV-CTL were generated by in vitro stimulation of peripheral blood leukocytes with autologous BLCL. CD8+ CTL were isolated from CTL populations by depletion of CD4+ cells. SCID mice were engrafted with BLCL, EBV-CTL were adoptively transferred into engrafted SCID mice either immediately or 7 days after engraftment, and the animals were monitored for the development of BCL. Statistical significance was determined by the log rank test. RESULTS: SCID mice engrafted with BLCL rapidly developed BCL (mean, 20 days). SCID mice engrafted with BLCL and human leukocyte antigen-identical EBV-CTL or CD8+ EBV-CTL had a significant delay in BCL development (p < 0.05), whereas some mice did not develop BCL. In contrast, human leukocyte antigen-nonidentical EBV-CTL did not significantly delay BCL development. CONCLUSIONS: This study showed the role of EBV-CTL in inhibiting the development of BCL. A greater understanding of the cellular and viral interactions leading to B-cell transformation and malignancy may allow the development of specific interventional therapies in patients who have received immunosuppressants.


Assuntos
Imunoterapia Adotiva , Linfoma de Células B/terapia , Transplante de Órgãos/efeitos adversos , Linfócitos T Citotóxicos/imunologia , Adulto , Animais , Linfócitos B/imunologia , Células-Tronco Hematopoéticas/imunologia , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/imunologia , Humanos , Ativação Linfocitária , Camundongos , Camundongos SCID
2.
Surg Oncol ; 2(1): 1-6, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8252190

RESUMO

The use of somatic gene therapy for the treatment of breast cancer has many potential applications. Because chemotherapeutic protocols for breast cancer are commonly limited by bone marrow toxicity, transduction of genes into pleuripotent stem cells may allow the generation and maintenance of immune responses in the presence of lymphocytotoxic agents. The practical utility of stem cell isolation and transduction would be enhanced if stem cells circulating in the peripheral blood could be isolated in patients, however this approach has been limited by the small numbers of such cells in the circulation. In these studies, recombinant granulocyte colony stimulating factor (G-CSF) was administered to patients with metastatic breast cancer to increase the number of circulating stem cells. Stem cells in the peripheral blood were then isolated and a retroviral vector (LXSN) was used to transduce the neomycin phosphotransferase gene into these cells. Gene transduction was demonstrated by resistance to the toxic effects of a neomycin analog (G418) and the detection of retroviral DNA from transduced cells. A practical method of transfer of exogenous genes into the circulating pleuripotent stem cells of patients with metastatic breast cancer is documented by these experiments. Application of these findings may allow the generation of cells resistant to anti-neoplastic agents or unique lymphoid effector cells with potent immune functions for the treatment of patients with metastatic breast cancer.


Assuntos
Neoplasias da Mama/terapia , Terapia Genética , Vetores Genéticos , Células-Tronco/efeitos dos fármacos , Sequência de Bases , Neoplasias da Mama/imunologia , DNA/análise , Resistência a Medicamentos/genética , Resistência a Medicamentos/imunologia , Feminino , Regulação Viral da Expressão Gênica , Gentamicinas/farmacologia , Humanos , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Retroviridae/genética , Células-Tronco/imunologia , Transfecção
3.
Surg Oncol ; 1(1): 79-86, 1992 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1341239

RESUMO

Cyclosporine (CsA) is a potent immunosuppressive agent primarily affecting T-lymphocyte function. Patients receive CsA following organ transplantation to prevent rejection. These patients are at high risk for developing Epstein-Barr virus (EBV)-induced lymphoproliferative disease (LPD) or B-cell lymphoma (BCL). Severe Combined Immunodeficient (SCID) mice reconstituted with human peripheral blood leukocytes (PBL) develop fatal B-cell lymphomas of human origin following latent or active infection with EBV. This model was utilized to determine the role of CsA in the development of human BCL. SCID mice were reconstituted with PBL, latently or actively infected with EBV, and treated with CsA. Following active EBV infection, mice developed human BCL with or without CsA treatment. In contrast, treatment with CsA prevented the development of BCL in mice latently infected with EBV. This suggests a T-cell interaction with latently infected B-cells which is perturbed by CsA. Further understanding of this interaction and the occurrence of human BCL may allow the development of strategies to prevent, detect, or treat malignancies associated with immunosuppression.


Assuntos
Ciclosporina/administração & dosagem , Linfoma de Células B/etiologia , Adulto , Animais , Relação Dose-Resposta a Droga , Imunofluorescência , Infecções por Herpesviridae/complicações , Infecções por Herpesviridae/imunologia , Infecções por Herpesviridae/patologia , Herpesvirus Humano 4 , Humanos , Imunoglobulina G/sangue , Transfusão de Leucócitos/métodos , Leucócitos/efeitos dos fármacos , Leucócitos/imunologia , Linfoma de Células B/imunologia , Linfoma de Células B/patologia , Linfoma de Células B/prevenção & controle , Camundongos , Camundongos SCID , Fatores de Tempo , Infecções Tumorais por Vírus/complicações , Infecções Tumorais por Vírus/imunologia , Infecções Tumorais por Vírus/patologia
4.
Fam Med ; 22(1): 20-4, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2303177

RESUMO

Adolescent pregnancy is a major adolescent health concern in the United States today, yet physicians often lack the knowledge and time to care properly for pregnant adolescents. this study examined the health concerns of pregnant adolescents and the ways in which the modern medical system deals with those concerns. Interviews with adolescents and health care workers in rural and urban neighborhoods showed that many adolescents are unaware of certain important personal matters that affect their health; the same holds true for some of those who work with these young people. All too often physicians are not trained to deal with many of the problems they encounter with pregnant adolescents. Many of the problems and concerns associated with adolescent pregnancy which directly affect the medical well-being of the mother and baby are not considered traditional medical problems: family experiences, superstitions, folk beliefs, culturally sanctioned interests, eating and sleeping habits. For the physician to successfully care for the adolescent mother and her child, these important concerns must be understood and addressed.


Assuntos
Mães/psicologia , Médicos de Família , Gravidez na Adolescência , Adolescente , Comportamento Alimentar , Feminino , Humanos , Papel do Médico , Gravidez , Cuidado Pré-Natal , Autoimagem
5.
Ann Surg Oncol ; 1(5): 405-10, 1994 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7531601

RESUMO

BACKGROUND: Severe combined immunodeficient (SCID) mice develop Epstein-Barr virus (EBV) containing human lymphoproliferative disease (LPD) tumors when reconstituted with human peripheral blood leukocytes (PBLs) from EBV-seropositive donors, but LPD tumors do not develop in the presence of immunosuppressive agents, such as cyclosporine A or corticosteroids. METHODS: Therefore, LPD development in SCID mice was used as a model to explore the relationship among B cells, T cells, and EBV in vivo. SCID mice were engrafted with PBLs isolated by leukapheresis from a single EBV-seropositive donor. Purified populations of CD3+ lymphocytes (T cells) or CD19+ lymphocytes (B cells) were isolated and engrafted into SCID mice. RESULTS: SCID mice engrafted with purified CD3+ lymphocytes (T cells) or CD19+ lymphocytes (B cells) did not develop LPD. In contrast, mice engrafted with purified B cells developed LPD if they were co-engrafted with purified T cells or if they were inoculated with infectious EBV. CONCLUSIONS: This study confirms the requirement of T cells or active EBV infection in the development of LPD in animals engrafted with B cells latently infected with EBV. A greater understanding of the cellular and viral interactions leading to transformation and malignancy may allow the development of specific interventional therapies for malignancies in the immunosuppressed host.


Assuntos
Transformação Celular Neoplásica/imunologia , Infecções por Herpesviridae/imunologia , Infecções por Herpesviridae/virologia , Herpesvirus Humano 4 , Transtornos Linfoproliferativos/imunologia , Transtornos Linfoproliferativos/virologia , Infecções Tumorais por Vírus/imunologia , Infecções Tumorais por Vírus/virologia , Animais , Antígenos CD/imunologia , Antígenos CD19 , Antígenos de Diferenciação de Linfócitos B/imunologia , Linfócitos B/imunologia , Linfócitos B/patologia , Linfócitos B/transplante , Complexo CD3/imunologia , Transformação Celular Neoplásica/patologia , Transplante de Células , Citometria de Fluxo , Infecções por Herpesviridae/patologia , Humanos , Injeções , Transtornos Linfoproliferativos/patologia , Camundongos , Camundongos SCID , Linfócitos T/imunologia , Linfócitos T/patologia , Infecções Tumorais por Vírus/patologia
6.
J South Orthop Assoc ; 9(2): 98-104, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10901647

RESUMO

We quantified the embolic load to the lungs created with two different techniques of femoral nailing. Eleven patients with 12 traumatic femur fractures were randomized to reamed (7 fractures) and unreamed (5 fractures) groups. Intramedullary nailing was with the AO/ASIF* universal reamed or unreamed nail. Transesophageal echocardiography (TEE) was used to evaluate the quantity and quality of emboli generated by nailing. Data were analyzed using software that digitized the TEE images and quantified the area of embolic particles in each frame. The duration of each level of embolic phenomena (zero, moderate, severe) was used to determine total embolic load with various steps (fracture manipulation, proximal portal opening, reaming, and nail passage). Manual grading of emboli correlated highly with software quantification. Our data confirm the presence and similarity of emboli generation with both methods of intramedullary nailing. Unreamed nails do not protect the patient from pulmonary embolization of marrow contents.


Assuntos
Ecocardiografia Transesofagiana , Fraturas do Fêmur/cirurgia , Fixação Intramedular de Fraturas/métodos , Complicações Intraoperatórias , Embolia Pulmonar/diagnóstico por imagem , Adolescente , Adulto , Embolia Gordurosa/diagnóstico por imagem , Embolia Gordurosa/etiologia , Feminino , Fixação Intramedular de Fraturas/efeitos adversos , Humanos , Complicações Intraoperatórias/diagnóstico por imagem , Masculino , Embolia Pulmonar/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA